Retraction
EphA2: a determinant of malignant cellular behavior and a potential therapeutic target in pancreatic adenocarcinoma
Paper Information
Record ID:
42564
Journal:
Publication Date:
February 19, 2004
Retraction Date:
February 09, 2023
(2.8 years years ago)
Subjects:
Broad Categories:
Biology
Biology
Country:
🇺🇸 United StatesArticle Type:
Publisher:
Springer - Nature Publishing Group
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Retraction Details
Retraction Reasons:
Nature of Retraction:
Retraction
Retraction Notice:
10.1038/s41388-023-02626-5Additional Notes:
see also: https://pubpeer.com/publications/5CD3A5CF37F120E2AE5390B007E2C8
Citations (219)
219
Total Citations9
Post-Retraction(4.1%)
208
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
1
Within 30 days
7
Within 1 year
0
After 2+ years
475
Days since retraction (latest)
Paper citing EphA2: a determinant of malignant cellular behavio...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing EphA2: a determinant of malignant cellular behavio...
Unknown Authors
Unknown Journal
Published: Unknown
Ephs in cancer progression: complexity and context-dependent nature in signaling, angiogenesis and immunity
Xiaoting Guo, Yanyi Yang, Jingqun Tang et al. (4 authors)
Cell Communication and Signaling
Open Access
Published: May 2024
7 citations
7 citations
475 days after retraction
Ephrin type-A receptor 2-antisense RNA1/2 promote proliferation and migration of MDA-MB-231 cells through EPHA2-dependent Ras signaling pathway mediated by MAPK8/JNK1, MAPK9/JNK2-NFATC2/NFAT1 and JUND
Tokifumi Odaka, Ryou Sakamoto, Kazuhiro Kumagai et al. (6 authors)
Frontiers in Molecular Biosciences
Open Access
Published: May 2024
1 citation
1 citation
470 days after retraction
A Comprehensive Review of Small Interfering RNAs (siRNAs): Mechanism, Therapeutic Targets, and Delivery Strategies for Cancer Therapy
Jiaying Zhang, Bo Chen, Chunyuan Gan et al. (6 authors)
International Journal of Nanomedicine
Open Access
Published: Dec 2023
62 citations
62 citations
295 days after retraction
Downregulation of EphA2 stability by RNF5 limits its tumor-suppressive function in HER2-negative breast cancers
Xiaojuan Li, Fan Wang, Lu Huang et al. (5 authors)
Cell Death and Disease
Open Access
Published: Oct 2023
5 citations
5 citations
243 days after retraction
Dual Tumor Exosome Biomarker Co-recognitions Based Nanoliquid Biopsy for the Accurate Early Diagnosis of Pancreatic Cancer
Zhiguo Yu, Yang� Yang, Wenming Fang et al. (6 authors)
ACS Nano
Published: Jun 2023
46 citations
46 citations
119 days after retraction
Combination of protein and cell internalization SELEX identifies a potential RNA therapeutic and delivery platform to treat EphA2-expressing tumors
Laura Santana-Viera, Justin P. Dassie, Marta Rosàs‐Lapeña et al. (14 authors)
Molecular Therapy — Nucleic Acids
Open Access
Published: May 2023
10 citations
10 citations
89 days after retraction
The Cell Biology of Metastatic Invasion in Pancreatic Cancer: Updates and Mechanistic Insights
Vidhu B. Joshi, Omar L. Gutierrez-Ruiz, Gina L. Razidlo
Cancers
Open Access
Published: Apr 2023
17 citations
17 citations
56 days after retraction
The role of EphA2 in ADAM17- and ionizing radiation-enhanced lung cancer cell migration
Verena Waller, Fabienne Tschanz, Rona Winkler et al. (4 authors)
Frontiers in Oncology
Open Access
Published: Mar 2023
4 citations
4 citations
33 days after retraction
Bioactive Piperazic Acid-Bearing Cyclodepsipeptides, Lydiamycins E–H, from an Endophytic <i>Streptomyces</i> sp. Associated with <i>Cinnamomum cassia</i>
Weihong Wang, Seung-Jin Kim, Thi Hanh Nguyen Vu et al. (15 authors)
Journal of Natural Products
Published: Feb 2023
7 citations
7 citations
13 days after retraction
Eph Receptors in Cancer
Sakshi Arora, Andrew M. Scott, Peter W. Janes
Biomedicines
Open Access
Published: Jan 2023
27 citations
27 citations
17 days before retraction
Proteolytic cleavage of membrane proteins by <scp>membrane type‐1 MMP</scp> regulates cancer malignant progression
Kazuki Ikeda, Ryo Kaneko, Eiki Tsukamoto et al. (5 authors)
Cancer Science
Open Access
Published: Nov 2022
6 citations
6 citations
94 days before retraction
Targefrin: A Potent Agent Targeting the Ligand Binding Domain of EphA2
Carlo Baggio, Parima Udompholkul, Luca Gambini et al. (4 authors)
Journal of Medicinal Chemistry
Open Access
Published: Nov 2022
13 citations
13 citations
97 days before retraction
Hunting for Novel Routes in Anticancer Drug Discovery: Peptides against Sam-Sam Interactions
Flavia Anna Mercurio, Marian Vincenzi, Marilisa Leone
International Journal of Molecular Sciences
Open Access
Published: Sep 2022
15 citations
15 citations
154 days before retraction
RNAi-based therapeutics and tumor targeted delivery in cancer
Göknur Kara, George A. Călin, Bülent Özpolat
Advanced Drug Delivery Reviews
Published: Jan 2022
275 citations
275 citations
386 days before retraction
Detection of serum EphA2-EVs for pancreatic cancer diagnosis by light initiated chemiluminescent assay
Wenhan Li, Xiaojun Yang, Tingting Bai et al. (8 authors)
Analytical Methods
Published: Jan 2022
8 citations
8 citations
404 days before retraction
Novel approaches in cancer treatment: preclinical and clinical development of small non-coding RNA therapeutics
Rossana Cuciniello, Stefania Filosa, Stefania Crispi
Journal of Experimental & Clinical Cancer Research
Open Access
Published: Dec 2021
49 citations
49 citations
432 days before retraction
Neoadjuvant therapy alters the collagen architecture of pancreatic cancer tissue via Ephrin-A5
Kosei Nakajima, Yoshinori Ino, Chie Naito et al. (12 authors)
British Journal of Cancer
Open Access
Published: Nov 2021
18 citations
18 citations
441 days before retraction
Surface enhanced Raman spectroscopy‐based immunoassay detection of tumor‐derived extracellular vesicles to differentiate pancreatic cancers from chronic pancreatitis
Nariman Banaei, Javad Moshfegh, Byung Gon Kim
Journal of Raman Spectroscopy
Published: Sep 2021
12 citations
12 citations
521 days before retraction
The Expression Profile and Prognostic Values of EPHA Family Members in Breast Cancer
Xixun Zhang
Frontiers in Oncology
Open Access
Published: Jun 2021
12 citations
12 citations
601 days before retraction
Effective Tumor Targeting by EphA2-Agonist-Biotin-Streptavidin Conjugates
Parima Udompholkul, Carlo Baggio, Luca Gambini et al. (7 authors)
Molecules
Open Access
Published: Jun 2021
6 citations
6 citations
602 days before retraction
EPHA2-dependent outcompetition of KRASG12D mutant cells by wild-type neighbors in the adult pancreas
William Hill, Ανδρέας Ζαραγκούλιας, Beatriz Salvador-Barberó et al. (11 authors)
Current Biology
Open Access
Published: Apr 2021
45 citations
45 citations
658 days before retraction
Tumor levels of the mediators of ErbB2-driven anoikis resistance correlate with breast cancer relapse in patients receiving trastuzumab-based therapies
Alexi P. Surette, Byong Hoon Yoo, Tallal Younis et al. (8 authors)
Breast Cancer Research and Treatment
Published: Mar 2021
9 citations
9 citations
695 days before retraction
Development of EphA2 siRNA-loaded lipid nanoparticles and combination with a small‐molecule histone demethylase inhibitor in prostate cancer cells and tumor spheroids
Ezgi Öner, Mustafa Kotmakçı, Anne‐Marie Baird et al. (8 authors)
Journal of Nanobiotechnology
Open Access
Published: Mar 2021
43 citations
43 citations
703 days before retraction
α1,6-Fucosyltransferase contributes to cell migration and proliferation as well as to cancer stemness features in pancreatic carcinoma
Caixia Liang, Tomohiko Fukuda, Tomoya Isaji et al. (7 authors)
Biochimica et Biophysica Acta (BBA) - General Subjects
Published: Feb 2021
20 citations
20 citations
730 days before retraction
The Expression of the Cancer-Associated lncRNA Snhg15 Is Modulated by EphrinA5-Induced Signaling
Daniel Pensold, Julia Gehrmann, Georg Pitschelatow et al. (11 authors)
International Journal of Molecular Sciences
Open Access
Published: Jan 2021
7 citations
7 citations
741 days before retraction
Vasculogenic mimicry, a complex and devious process favoring tumorigenesis – Interest in making it a therapeutic target
Lucas Treps, Sébastien Faure, Nicolas Clere
Pharmacology & Therapeutics
Open Access
Published: Jan 2021
70 citations
70 citations
752 days before retraction
Mechanisms of vasculogenic mimicry in hypoxic tumor microenvironments
Xiaoxu Wei, Yunhua Chen, Xianjie Jiang et al. (19 authors)
Molecular Cancer
Open Access
Published: Jan 2021
339 citations
339 citations
766 days before retraction
A T cell redirection platform for co-targeting dual antigens on solid tumors
Leonie Enderle, Karim H. Shalaby, Maryna Gorelik et al. (10 authors)
mAbs
Open Access
Published: Jan 2021
6 citations
6 citations
769 days before retraction
PIP2 promotes conformation-specific dimerization of the EphA2 membrane region
Katherine M. Stefanski, C. Russell, Justin M. Westerfield et al. (5 authors)
Journal of Biological Chemistry
Open Access
Published: Dec 2020
32 citations
32 citations
796 days before retraction
PIP<sub>2</sub>promotes conformation-specific dimerization of the EphA2 membrane region
Katherine M. Stefanski, C. Russell, Justin M. Westerfield et al. (5 authors)
bioRxiv (Cold Spring Harbor Laboratory)
Open Access
Published: Oct 2020
3 citations
3 citations
848 days before retraction
Development of EphA2 siRNA-loaded lipid nanoparticles and combination with a small-molecule histone demethylase inhibitor in prostate cancer cells and tumor spheroids
Ezgi Öner, Mustafa Kotmakçı, Anne‐Marie Baird et al. (8 authors)
bioRxiv (Cold Spring Harbor Laboratory)
Open Access
Published: Sep 2020
864 days before retraction
Chimeric Antigen Receptor-modified T cells targeting EphA2 for the immunotherapy of paediatric bone tumours
Kenneth Hsu, Shiloh Middlemiss, Federica Saletta et al. (6 authors)
Cancer Gene Therapy
Open Access
Published: Sep 2020
39 citations
39 citations
891 days before retraction
Targeting EphA2 in cancer
Ta Xiao, Yuhang Xiao, Wenxiang Wang et al. (6 authors)
Journal of Hematology & Oncology
Open Access
Published: Aug 2020
177 citations
177 citations
905 days before retraction
Microdissected pancreatic cancer proteomes reveal tumor heterogeneity and therapeutic targets
Tessa Y. S. Le Large, Giulia Mantini, Laura L. Meijer et al. (14 authors)
JCI Insight
Open Access
Published: Jul 2020
53 citations
53 citations
947 days before retraction
Therapeutic siRNA: state of the art
Bo Hu, Liping Zhong, Yuhua Weng et al. (7 authors)
Signal Transduction and Targeted Therapy
Open Access
Published: Jun 2020
1177 citations
1177 citations
965 days before retraction
THE EPHA2/EPHRIN-A1 AXIS REGULATES HOST-TUMOR INTERACTIONS
Eileen Shiuan
Unknown Journal
Published: May 2020
996 days before retraction
Therapeutic Targeting of Pancreatic Cancer via EphA2 Dimeric Agonistic Agents
Ahmed F. Salem, Luca Gambini, Parima Udompholkul et al. (5 authors)
Pharmaceuticals
Open Access
Published: May 2020
11 citations
11 citations
1005 days before retraction
The role of Eph receptors in cancer and how to target them: novel approaches in cancer treatment
Oscar J Buckens, Btissame El Hassouni, Elisa Giovannetti et al. (4 authors)
Expert Opinion on Investigational Drugs
Open Access
Published: Apr 2020
60 citations
60 citations
1016 days before retraction
Vascular mimicry: Triggers, molecular interactions and in vivo models
Stephen L. Wechman, Luni Emdad, Devanand Sarkar et al. (5 authors)
Advances in cancer research
Open Access
Published: Jan 2020
75 citations
75 citations
1135 days before retraction
<p>Baohuoside I Inhibits the Proliferation of Pancreatic Cancer Cells via mTOR/S6K1-Caspases/Bcl2/Bax Apoptotic Signaling</p>
Fubiao Ni, Hengjie Tang, Cheng Wang et al. (8 authors)
Cancer Management and Research
Open Access
Published: Dec 2019
12 citations
12 citations
1166 days before retraction
Bioinformatics Predictions, Expression, Purification and Structural Analysis of the PE38KDEL-scfv Immunotoxin Against EPHA2 Receptor
Ehsan Rezaie, Ali Bidmeshki Pour, Jafar Amani et al. (4 authors)
International Journal of Peptide Research and Therapeutics
Published: Aug 2019
25 citations
25 citations
1284 days before retraction
Rapid Lipid-Based Approach for Normalization of Quantum-Dot-Detected Biomarker Expression on Extracellular Vesicles in Complex Biological Samples
Meryl Rodrigues, Nicole Richards, Bo Ning et al. (5 authors)
Nano Letters
Open Access
Published: Jul 2019
41 citations
41 citations
1302 days before retraction
EPHA2 feedback activation limits the response to PDEδ inhibition in KRAS-dependent cancer cells
Yuehong Chen, Hao Lv, Ning Shen et al. (9 authors)
Acta Pharmacologica Sinica
Open Access
Published: Jul 2019
9 citations
9 citations
1303 days before retraction
Tumor cell–intrinsic EPHA2 suppresses antitumor immunity by regulating PTGS2 (COX-2)
Nune Markosyan, Jinyang Li, Yu Sun et al. (16 authors)
Journal of Clinical Investigation
Open Access
Published: Jun 2019
146 citations
146 citations
1346 days before retraction
RNAi therapeutic and its innovative biotechnological evolution
Yuhua Weng, Haihua Xiao, Jinchao Zhang et al. (5 authors)
Biotechnology Advances
Published: Apr 2019
255 citations
255 citations
1385 days before retraction
Limited importance of EphrinA1–ligand, Src kinase, and focal adhesion kinase in EphA2-mediated regulation of metastasis in Mel-Juso and A375 human melanoma cells
Christin Neuber, Nadine Herwig, Jens Pietzsch et al. (4 authors)
Journal of Cellular Biotechnology
Published: Apr 2019
1 citation
1 citation
1389 days before retraction
HNF6 promotes tumor growth in colorectal cancer and enhances liver metastasis in mouse model
Kai Jiang, Yurong Jiao, Yue Liu et al. (10 authors)
Journal of Cellular Physiology
Published: Sep 2018
17 citations
17 citations
1616 days before retraction
Structure-Based Design of Novel EphA2 Agonistic Agents with Nanomolar Affinity <i>in Vitro</i> and in Cell
Luca Gambini, Ahmed F. Salem, Parima Udompholkul et al. (9 authors)
ACS Chemical Biology
Open Access
Published: Aug 2018
29 citations
29 citations
1639 days before retraction
Quick Stats
Total Citations:
219
Years Since Retraction:
2.8 years
Open Access:
Yes
Last Checked:
Jul 24, 2025